13FPulse
中
AC

ACRS ACLARIS THERAPEUTICS INC

2026Q2 · CUSIP 00461U105 · Sector: Healthcare & Biotech

Normal

Fund flows are within the usual range

Funds that own it
146
Institutions that reported holding it to the SEC
Net increase in holders
+11
Last quarter 135 → now 146
How unusual is that
Above average
Stronger buying than 71% of US stocks
What the filings say, in one paragraph

146 funds held ACRS at the end of 2026Q2, up 11 from the quarter before. Fund flows are within the usual range — nothing unusual. On the business itself, revenue over the last 12 months was $8M(YoY -51.0%), return on equity is -60.8%. ACRS has had 8 buying rushes in its history, and the price moved -26.7% on average over the six months after (that is the raw price move, not how much it beat the market by). It sits in the Healthcare & Biotech sector.

How many funds owned it, quarter by quarter

Bars = net change in institutional holders, positive (green) or negative (red). Line = total institutional holders.

2016Q1: holders=32 2016Q2: holders=46 2016Q3: holders=58 2016Q4: holders=99 2017Q1: holders=112 2017Q2: holders=105 2017Q3: holders=105 2017Q4: holders=103 2018Q1: holders=101 2018Q2: holders=96 2018Q3: holders=86 2018Q4: holders=99 2019Q1: holders=95 2019Q2: holders=85 2019Q3: holders=80 2019Q4: holders=80 2020Q1: holders=71 2020Q2: holders=62 2020Q3: holders=57 2020Q4: holders=82 2021Q1: holders=96 2021Q2: holders=128 2021Q3: holders=126 2021Q4: holders=134 2022Q1: holders=111 2022Q2: holders=115 2022Q3: holders=128 2022Q4: holders=129 2023Q1: holders=149 2023Q2: holders=133 2023Q3: holders=138 2023Q4: holders=107 2024Q1: holders=98 2024Q2: holders=98 2024Q3: holders=81 2024Q4: holders=98 2025Q1: holders=107 2025Q2: holders=95 2025Q3: holders=103 2025Q4: holders=122 2026Q1: holders=135 2026Q2: holders=146 -41 -20.5 +0 +20.5 +41 2893157 16Q117Q218Q319Q421Q122Q223Q324Q426Q126Q2 Net change in holders (bars) Total funds holding (line)

What happened after each past buying rush 8 times in its history

Quarter of the rush How unusual then Price, next 3 months Price, next 6 months
2023Q1 Top 10% -13.8% -90.3%
2022Q3 Top 20% -26.9% -54.5%
2021Q2 Top 10% +6.0% -4.6%
2018Q4 Top 20% -24.0% -88.2%
2017Q1 Top 20% +4.0% -12.8%
2016Q4 Top 10% -5.5% -8.0%
2016Q3 Top 20% +22.0% +8.7%
2016Q2 Top 20% +16.2% +36.2%

These are the raw price moves, not how much it beat the market by. Compare them against the market over the same months — in a strong bull market almost everything is up.

Show all the numbers (large funds, value held, options…) ▾
Of them, large funds
82
Change in large funds
+5
Total value they hold
$622M
Funds buying for the first time
29
Funds that sold out entirely
18
Price change that quarter
+40.5%
Funds holding puts (bearish)
2
Funds holding calls (bullish)
4

These are for people who want to dig. Skip them if they do not mean anything to you — the three numbers above are enough.

8,697 institutions have filed for this quarter. 13F permits late filing and a small number arrive in the weeks after the deadline, so the holder counts and changes below may tick up.

Fundamentals

PE (TTM)
—
EPS (TTM)
$-0.58
EPS YoY
—
Revenue (TTM)
$0.0B
Revenue YoY
-51.0%
Net margin
—
ROE
-60.8%
Debt ratio
30.7%
FCF (TTM)
-$62M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS
2025-03-31: EPS -0.12 2025-06-30: EPS -0.13 2025-09-30: EPS -0.12 2025-12-31: EPS -0.16 2026-03-31: EPS -0.15 2026-06-30: EPS -0.15 0M 10M 19M $M -0.18 -0.09 0.00 201720182019202020212022202320242025202606/26 Revenue EPS

Quarterly figures, revenue up to 10 years back; EPS split-adjusted, early quarters hidden when not calibrable

Quarterly free cash flow
-32M-5M22M 20162017201820192020202120222023202420252026
Latest quarter $-18M (2026-03-31)

FCF = operating cash flow − capex, computed from SEC XBRL; banks/insurers have no standard cash-flow structure and are hidden

As of 2026-06-30 · SEC filings (XBRL)

Email me the next update

2026 Q3 holdings are due 2026-11-16. We will email you when the refreshed lists are live.